“America’s manufacturers came together during COVID to rapidly and successfully ramp up production of healthcare equipment,” said CPA Chair Zach Mottl. “However, many of the Section 301 China tariffs were also waived at the same time, undercutting incentives to invest in domestic production. Now that the emergency declared under the Public Health Service Act is expiring, there’s no need to keep waiving the tariffs. Continuing the tariff exclusions would only benefit foreign manufacturers in adversarial nations like China while telling U.S. producers the government is not really interested in building production here.”

Read the article.